Physician profile
Seth Lapin
NPI 1427042613
$2,106.82
in general payments reported to CMS, 2019-2025
16 companies · $749 in 2025
The $749 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $159 · 2021: $138 · 2022: $407 · 2023: $209 · 2024: $287 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $574.26 | 2020-2025 | |
| Boston Scientific Corporation | $348.09 | 2019-2025 | Varithena Administration Pack, Exalt Model D |
| Olympus America INC. | $214.28 | 2019-2021 | |
| Janssen Biotech, INC. | $192.86 | 2022-2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $151.57 | 2022-2025 | Entyvio |
| Pfizer INC. | $125.00 | 2024 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2023 | Xifaxan |
| Gilead Sciences, INC. | $117.54 | 2022 | |
| Cook Medical LLC | $28.01 | 2021 | |
| Lilly USA, LLC | $22.72 | 2024 | Zepbound, Omvoh |
| Daiichi Sankyo INC. | $18.81 | 2022 | |
| Steris Corporation | $18.56 | 2021 | |
| W. L. Gore & Associates, INC. | $17.29 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $13.94 | 2024 | Suretrac |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Lapin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.